SAGE Therapeutics Careers NewsEmployer Directory Featured Listing, Feeds and Subscriptions

The latest SAGE Therapeutics' careers news and job posts. Subscribe for daily updates to your inbox, mobile device and/or smartphone.

  Jobs Feed | Subscribe  

**General Scope and Summary** SAGE Therapeutics is searching for a creative, resourceful, integrative thinker for an important role that is responsible to set Clinical Pharmacology strategy for clinical development plans across the portfoli...
Posted: April 19, 2019, 7:19 am
**General Scope and Summary** SAGE Therapeutics is searching for a resourceful, integrative thinker for an important role that is responsible for Quality Assurance operations oversight and support of clinical development projects within CMC...
Posted: April 18, 2019, 3:17 pm
**General Scope and Summary** SAGE Therapeutics is searching for a creative, resourceful, integrative thinker to plan, develop, and manage innovative benefit and wellness programs, with a family-centric focus, that excite great talent to jo...
Posted: April 18, 2019, 3:17 pm
**General Scope and Summary** SAGE Therapeutics is searching for a creative, resourceful, integrative thinker for an important role developing compensation strategies and programs that excite great talent to join our team, do their best wor...
Posted: April 18, 2019, 3:17 pm
**General Scope and Summary** SAGE Therapeutics is searching for a creative, analytical, and customer focused team player to play an important role in ensuring that patients have access to the SAGE portfolio of products. This role will focu...
Posted: April 12, 2019, 8:43 am

Viewing page 1 of 12|Next Page

  Newsfeed | Subscribe  

The University of California licensed UCD’s patented discovery to publicly traded Sage Therapeutics, a biopharmaceutical company based near Boston, and the company’s share price has risen since March ...
Posted: April 15, 2019, 2:20 am
New York, NY -- (SBWIRE) -- 04/10/2019 -- Study papers on Postpartum Depression Treatment Market and regional forecast. Postpartum Depression Treatment Market top players including are Allergan ...
Posted: April 10, 2019, 4:43 am
WARSAW, Poland — Women with postpartum depression (PPD) can achieve rapid remission with a 60-hour infusion of brexanolone (Zulresso, Sage Therapeutics), and remission is sustained over 30 days, a ...
Posted: April 9, 2019, 11:26 am
One intravenous infusion of brexanolone, which is being marketed by the manufacturer Sage Therapeutics as Zulresso, will likely cost an average of $34,000 without insurance. Administered over a period ...
Posted: April 2, 2019, 1:35 pm
March 19 The U.S. Food and Drug Administration on Tuesday approved https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm633919.htm Sage Therapeutics Inc's drug for postpartum depression, ...
Posted: March 30, 2019, 5:00 pm

Viewing page 1 of 2|Next Page